Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 375,168 | 113,938 | 89,237 | 82,425 | 79,391 |
| Marketable Securities | 291,596 | 369,616 | 404,205 | 510,436 | 336,465 |
| Receivables | 25,107 | 23,412 | 5,076 | 5,264 | N/A |
| Inventories | 2,665 | N/A | N/A | N/A | N/A |
| TOTAL | $704,683 | $516,786 | $513,726 | $612,952 | $426,516 |
| Non-Current Assets | |||||
| PPE Net | 37,822 | 38,361 | 38,310 | 33,525 | 30,615 |
| Investments And Advances | 83,666 | 64,406 | 101,017 | 74,398 | 0 |
| Other Non-Current Assets | 87,452 | 88,141 | 84,872 | 86,303 | 87,532 |
| TOTAL | $208,940 | $190,908 | $224,199 | $194,226 | $118,147 |
| Total Assets | $913,623 | $707,694 | $737,925 | $807,178 | $544,663 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,468 | 4,793 | 2,203 | 6,608 | 4,421 |
| Accrued Expenses | 73,961 | 88,706 | 80,419 | 64,126 | 50,826 |
| TOTAL | $98,288 | $106,482 | $94,142 | $81,506 | $64,763 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 8,690 | 6,160 | 4,933 | 4,415 | 4,238 |
| Other Non-Current Liabilities | 95,595 | 96,940 | 91,041 | 92,790 | 94,489 |
| TOTAL | $132,404 | $136,853 | $127,439 | $132,845 | $135,687 |
| Total Liabilities | $230,692 | $243,335 | $221,581 | $214,351 | $200,450 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,190 | 54,027 | 49,202 | 49,116 | 48,854 |
| Common Shares | 54 | 49 | 49 | 49 | 44 |
| Retained earnings | -1,056,194 | -945,238 | -878,908 | -784,633 | -684,952 |
| Other shareholders' equity | -69 | -2,535 | 637 | 927 | 75 |
| TOTAL | $682,931 | $464,359 | $516,344 | $592,827 | $344,213 |
| Total Liabilities And Equity | $913,623 | $707,694 | $737,925 | $807,178 | $544,663 |